Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
Prevalence rates of delirium range widely depending on patient population and treatment setting. Information on rates of delirium in community settings is limited, but in emergency and hospital settings, one-quarter or more of the patients will experience delirium. Rates can be even higher in older individuals, critical care patients, and patients who have had major orthopedic or cardiovascular surgeries.
Prevention, early detection, and optimal treatment are critical because delirium is often unrecognized and is associated with increased morbidity and mortality. For example, postsurgical delirium has been reported to have a 30-day mortality rate of up to 10%, versus 1% in postsurgical patients without delirium. Additionally, delirium exacts a significant economic toll on individuals, their families, and society because of longer hospital stays, ICU admissions, rehospitalizations, and lost wages. In the United States, direct health care costs of hospitalized older adults with delirium are significantly higher than hospitalized patients without delirium, even after adjusting for demographic and clinical factors.
The American Psychiatric Association Practice Guideline for the Prevention and Treatment of Delirium reviews current evidence-based nonpharmacological and pharmacological interventions to prevent or treat delirium in adults. In addition, it includes statements related to assessment and treatment planning, which are an integral part of patient-centered care. The guideline describes approaches to implementing recommendations and suggestions in clinical practice. By providing up-to-date knowledge, the guideline aims to help clinicians feel more confident in preventing, recognizing, and treating delirium, thereby improving the care and well-being of their patients.
Evidence tables, literature search results, clinical questions, and more for this guideline can be found in the online appendixes.
Guideline Writing Group
Systematic Review Group
Committee on Practice Guidelines
APA Assembly Liaisons
Table of Contents
Acronyms/Abbreviations
Introduction
Chapter 1. Guideline Statement Summary
Chapter 2. Guideline Statements and Implementation
Chapter 3. Nonpharmacological Interventions
Chapter 4. Pharmacological Interventions
Chapter 5. Transitions of Care
Chapter 6. Areas for Further Research
Chapter 7. Guideline Development Process
Appendices
Appendix A. Clinical Questions
Appendix B. Search Strategies, Study Selection, and Search Results
Appendix C. Review of Research Evidence Supporting Guideline Statements
Appendix D. Evidence Tables for Individual Studies Supporting Guideline Statements
Appendix E. Risk of Bias Ratings for Individual Studies Supporting Guideline Statements
Appendix F. Review of Benefits and Harms, Patient Preferences, and Other Practice Guidelines
Appendix G. Description of Additional Studies Reviewed
Appendix H. Evidence Tables for Additional Studies Reviewed
Appendix I. Considerations in the Use of Guidelines to Enhance the Quality of Care
References